SMUG1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of SMUG1 monoclonal antibodies for advanced research in molecular biology. SMUG1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SMUG1, or Single-Strand Selective Monofunctional Uracil-DNA Glycosylase 1, plays a vital role in DNA repair by recognizing and excising uracil from DNA, thereby maintaining genomic stability. SMUG1 helps prevent mutations that can lead to various diseases, including cancer. Understanding SMUG1 function and regulation provides insights into DNA damage response and repair mechanisms. Researchers worldwide rely on SMUG1 monoclonal antibodies to advance their studies in DNA repair pathways. Current investigations focus on how SMUG1 interacts with other DNA repair proteins to maintain cellular health. Ongoing research explores SMUG1's potential as a therapeutic target in cancer treatment. Santa Cruz Biotechnology monoclonal antibodies for SMUG1 enable researchers to make meaningful contributions to understanding DNA repair mechanisms and their impact on human health.